Navigation Links
Reportlinker Adds Tumor Markers - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
Date:5/5/2011

s 71

Table 44: Xeptagen, Tumor Markers, Pipeline Products 71

Table 45: Epi proColon-mSEPT9 - Clinical Trial 75

Table 46: Epi proColon-mSEPT9 - Clinical Trial 76

Table 47: Lung Cancer Screening Test - Clinical Trial 77

Table 48: DCP-IgM Liver Cancer Test - Clinical Trial 78

Table 49: AdnaTest BreastCancer - Clinical Trial 80

Table 50: AdnaTest BreastCancer - Clinical Trial 81

Table 51: AdnaTest BreastCancer - Clinical Trial 82

Table 52: AdnaTest BreastCancer - Clinical Trial 83

Table 53: AdnaTest ColonCancer - Clinical Trial 84

Table 54: ColoMark CCSA-4 Serum Assay - Clinical Trial 87

Table 55: Precision Profile-Prostate Cancer Early Detection Clinical Trial 88

Table 56: Diagnostic Marker-Colorectal Cancer - Clinical Trial 90

Table 57: Diagnostic Marker-Colorectal Cancer - Clinical Trial 91

Table 58: Semi-Quantitative Test for Uterine Cancer - Clinical Trial 93

Table 59: Biomarker mGSTP1-Prostate Cancer - Clinical Trial 95

Table 60: BCtect - Breast Cancer - Clinical Trial 96

Table 61: BronchoGen - Clinical Trial 98

Table 62: Early Stage Lung Cancer Diagnostic test - Clinical Trial 100

Table 63: P2V Prostate Cancer Test - Clinical Trial 102

Table 64: P2V Prostate Cancer Test - Clinical Trial 102

Table 65: Gastric Cancer Diagnostic Test - Clinical Trial 103

Table 66: Genefec III - Clinical Trial 104

Table 67: Genefec III - Clinical Trial 104

Table 68: Molecular Diagnostic Tests For Bladder Cancer - Clinical Trial 108

Table 69: Molecular Diagnostic Tests For Bladder Cancer - Clinical Trial 109

Table 70: NADiA ProsVue - Clinical Trial 110

Table 71: OncoDefender-CRC - Clinical Trial 111

Table 72: OvPlex 2nd Generation - Clinical Trial 113

Table 73: OvPlex 2nd Generation - Clinical Trial 114

Table 74: PROGENSA PCA3 Assay - Clinical Trial 115

Table 75: P
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. Reportlinker Adds Biomarkers: Technologies and Global Markets
2. Reportlinker Adds Medical Enzymes: Technologies and Global Markets
3. Reportlinker Adds Case Study: Personalized Cancer Therapy - The era of biomarker identification and companion diagnostic co-development
4. Reportlinker Adds R&D Trends: Osteoporosis - Strong pipeline bodes well for future treatment
5. Reportlinker Adds Molecular Diagnostics Market: DNA Probes And Biochips
6. Reportlinker Adds Competitor Analysis: Targeted Therapy of Diabetes
7. Reportlinker Adds China Bio-breeding Industry Report, 2010
8. Reportlinker Adds Neurology Devices Market Outlook in China to 2017 - Neurostimulation Devices, Interventional Neurology and Other
9. Reportlinker Adds Biomarker Partnering Terms and Agreements
10. Reportlinker Adds Top & Emerging Bio-Fuel Markets by Technology, Feedstocks, Regulations, Pricing & Commercialization Trends & Forecasts (2011 - 2016)
11. Reportlinker Adds Industrial Biotechnology China News 1103
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... 2015  Prima Biomed Ltd. (NASDAQ: PBMD ) ... become a leader in the development of immunotherapeutic products ... final CVac data from the Phase II CAN-003 ovarian ... a clinically meaningful improvement in Overall Survival ("OS") over ... In the group of second remission patients (n=20), ...
(Date:5/21/2015)... , May 21, 2015 ... inner feelings - and those of others. Being able ... senses. Analyze and read people to anticipate their thoughts ... your deepest emotions and feelings to create unique abstract ... of responsive games. Get inside a first-person-shooter as it ...
(Date:5/21/2015)... , May 21, 2015  CytRx Corporation ... development company specializing in oncology, today announced positive ... trial with aldoxorubicin for the treatment of unresectable ... cancer.  The open-label, multisite trial is designed to ... in patients whose tumors have progressed following prior ...
(Date:5/21/2015)... /PRNewswire/ - RepliCel Life Sciences Inc. (TSX.V: RP) ... focused on the development of autologous cell therapies, ... International Society for Cellular Therapy (ISCT) on RepliCel,s ... in a Phase 1/2 clinical trial.  The presentation, ... 5:30 PM to 7:00 PM local time, will ...
Breaking Biology Technology:Correction Continues after Big Move - BrokerBank Securities, Inc. 25 Days to Meet ARGUS - The World's First Contactless Emotions Scanner 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 2RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference 3
... June 17 Schering-Plough,Corporation (NYSE: SGP ) is ... 2008 second quarter on Monday, July 21, 2008., ... conduct a conference,call to review results for the 2008 ... members of management will,host the conference call., To ...
... 17 Mergent, Inc., administrator for the,HealthShares(TM) Indexes, ... Exchange Traded Funds, today announced the quarterly,rebalancing of ... and,deleted in the Indexes effective before the opening ... HealthShares(TM) Autoimmune-Inflammation Index (HHA), Drop, ...
... NEW HAVEN, Conn., June 17 BioXcel ... ASDO Consulting Group,(ASDO), a leading consulting company ... global business analytics company, will combine forces ... of,services. These include business analytics to support,licensing/due-diligence, ...
Cached Biology Technology:Schering-Plough Schedules Conference Call and Webcast for 2008 Second Quarter Earnings 2Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 2Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 3Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 4Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 5Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 6Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 7Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 8Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 9Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 10Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 11Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 12Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 13Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 14Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 15Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 16Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 17Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 18Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 19Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 20Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 21Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 22Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 23Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 24Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 25Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 26Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 27Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 28Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 29Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 30Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 31Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 32Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes 33BioXcel Expands Its Capability in Business Analytics Support Services 2
(Date:5/14/2015)... 14, 2015 Research and Markets ( ... "Fingerprint Sensors Market in Smart Mobile Devices " ... that 2014 was a watershed year for fingerprint sensors ... ,Apple Pay,. Apple gave fingerprint sensors a raison d,etre ... Fingerprint sensors are a must-have feature in flagship smartphones. ...
(Date:5/11/2015)... Curemark LLC, a privately held drug research ... Phase III double blind, randomized, placebo-controlled clinical trial to ... all children ages 3-8 with Autism. Previously, Curemark announced ... blinded clinical trial for CM-AT in children ages 3-8 ... enzyme chymotrypsin. This new trial will help determine whether ...
(Date:5/6/2015)... 6, 2015 LifeBEAM, a developer of bio-sensing ... announced today that they will expand their partnership in ... bio-sensing cycling helmet and the first joint project between ... colors in order to give cyclists more style choices ... LifeBEAM and Lazer announced their plan to release a ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... a large epidemiologic study, researchers at UCLA,s Jonsson Cancer ... are at higher risk of having retinoblastoma, a malignant ... under six. The study, which focused on babies ... fathers were at greater risk for retinoblastoma, as were ...
... can encounter a host of health complications. The added weight ... at least initially. In a new study published in ... a University of Iowa researcher compared the weight and height ... born to normal-weight mothers. Contrary to expectations, babies ...
... -- A commercial vaccine for cattle can effectively reduce levels ... a Kansas State University study has found. The vaccine is ... doses, which can help cut costs for the beef industry. ... investigator on a project that researched the effectiveness of products ...
Cached Biology News:US-born Latinas at great risk of having babies with retinoblastoma 2Infants of overweight mothers grow more slowly 2Infants of overweight mothers grow more slowly 3A new line of defense: Researchers find cattle vaccine works to reduce E. coli O157:H7 2
The FliTrx Panning Kit is designed to simplify panning for protein-protein interactions with the FliTrx Random Peptide Display Library or the pFliTrx Peptide Display Vector....
... GeneSwitch Cell Lines stably express the ... cell line is functionally tested for ... the expression control vector pGene/V5-His/lacZ and ... treatment with mifepristone (Figure 1). These ...
... Modules Highly efficient ... cloning into advanced λ ... For flexibility ... Systems, the modules of ...
... The CHEMICON Re-Blot Western Blot ... of antibodies from Western blots that ... radioactive iodine or other isotopes. It ... substrates (TMB, DAB, 4-chloronapthol, etc.), as ...
Biology Products: